NASDAQ:RNXT

Renovorx Stock Predictions

etoro logo Buy RNXT
*Your capital is at risk
$0.91
-0.0049 (-0.538%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

RNXT Prediction Chart

RNXT Predictions History

Latest community submissions for RNXT.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 30, 2026 $0.86 +4.00% $0.85 V 98.31% 1
Apr 30, 2026 $0.86 +3.35% $0.85 V 98.95% 2
Apr 30, 2026 $0.85 +2.09% $0.85 V 99.82% 6
Apr 30, 2026 Bullish $0.85 V 1
Apr 23, 2026 $0.92 -3.20% $0.90 V 98.01% 1
Apr 23, 2026 $0.98 +3.20% $0.90 X 91.26% 0
Apr 23, 2026 $0.97 +2.00% $0.90 X 92.52% 0
Apr 23, 2026 Bullish $0.90 X 0
Mar 2, 2026 $0.91 +3.08% $0.88 X 96.78% 0
Mar 2, 2026 $0.90 +1.92% $0.88 X 97.94% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RNXT with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT RENOVORX, INC.
RenovoRx
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California....
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE